Success Stories: EB-1A Approved for Biophysics Researcher Advancing RNA-Targeted Antivirals and Protein–Drug Interactions following RFE

Client’s Testimonial:

“My immigration journey began with the Chen Team in April 2023. I am deeply grateful for the comprehensive guidance and support they provided throughout the preparation of my EB1A application. I would like to extend particular appreciation to my attorney and her team, who demonstrated exceptional expertise in responding to the Request for Evidence (RFE). Their response was meticulously crafted, incorporating relevant case law and citations from the USCIS Policy Manual to effectively address the concerns raised. The Team skillfully emphasized that USCIS bears the responsibility to evaluate all evidence with appropriate nuance and to consider the collective weight of all supporting documentation when rendering their final decision.”

On August 16^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Specialist II in the field of Biophysics (Approval Notice).

General Field: Biophysics

Position at the Time of Case Filing: Research Specialist II

Country of Origin: India

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: August 16^th, 2025

Processing Time: 3 months, 26 days (Premium Processing Requested)

Case Summary:

North America Immigration Law Group (NAILG) framed this EB-1A case around a record that couples high-resolution biophysical methods with drug-discovery insight to address oncology and infectious disease. The petition highlighted the client’s ongoing U.S. research role developing NMR-guided strategies and translational tools to improve diagnostics and therapeutics.

Research Focus and Contributions

Cancer & inflammation pathways: Structural mapping of a disease-relevant protein–receptor complex and demonstration that small molecules disrupt the interaction, informing anti-metastatic strategies.
Host–virus regulation: Discovery work on hnRNP-mediated alternative splicing that impacts HIV-1
Antiviral therapeutics: Identification of an RNA-targeted small molecule that represses enterovirus 71 replication by stabilizing a translation-repressive complex, establishing a paradigm for modulating structured viral RNA.
COVID-19 mechanisms: Conserved SARS-CoV-2 RNA elements and host-signaling effects that control viral translation, pointing to new intervention points.

Research Impact and Metrics

Peer-Reviewed Publications: 17 journal articles (including first-authored work).
Citations: 305 independent citations by international teams.
Peer-Review Service: 40+ completed manuscript reviews; service on multiple editorial boards.

Demonstrating Extraordinary Ability

NAILG met the EB-1A criteria by documenting: judging the work of others (dozens of invited peer-review assignments and editorial-board roles); original contributions of major significance (structural models and RNA-targeted antiviral mechanisms adopted and extended by independent groups worldwide); and authorship in selective venues with objective indicators of influence (multiple highly cited works relative to year-and-field baselines) and contributed significantly to operational support, user services, and the strategic expansion of NMR core facilities at multiple academic institutions.

Well Positioned for Continued Innovation

The record shows advanced training, sustained U.S. research employment, and a cohesive plan to expand NMR-guided discovery, structural modeling of disease complexes, and RNA-focused antivirals, evidence of the capacity to keep producing results with U.S. public-health and economic benefit. Expert recommendation letters corroborate broad reliance on these methods and findings.

Approval and Outcome

After an RFE early in adjudication, USCIS approved the petition in 3 months and 26 days. NAILG is proud to have guided this EB-1A case to approval and looks forward to the client’s continued contributions to cancer targets, antiviral design, and biomedical innovation in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.